The revenue stands at ₹3,302.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 3.90 per cent from ₹3,178.00 crore. This corresponds to a year-on-year *(YoY) growth of 14.30 per cent.
Operating Profit stands at ₹21.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 10.53 per cent from ₹19.00 crore. This corresponds to a year-on-year *(YoY) decline of 56.25 per cent.
PBDT stands at ₹404.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 3.32 per cent from ₹391.00 crore. This corresponds to a year-on-year *(YoY) decline of 0.49 per cent.
Profit Before Tax stands at ₹791.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 7.18 per cent from ₹738.00 crore. This corresponds to a year-on-year *(YoY) growth of 19.67 per cent.
Net Profit stands at ₹604.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 10.22 per cent from ₹548.00 crore. This represents a 33.33 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Torrent Pharma. | -2.45% | -3.90% | 2.53% | 9.86% | 11.81% | 21.05% |
| Sun Pharma.Inds. | -0.17% | -2.50% | -6.09% | -4.00% | -3.57% | -10.44% |
| Divi's Lab. | -1.16% | -2.12% | -7.46% | -8.76% | -9.19% | 4.24% |
| Cipla | -4.35% | -5.49% | -12.13% | -16.98% | -11.59% | -6.87% |
| Dr Reddy's Labs | 1.48% | 5.89% | -2.46% | -3.80% | -2.35% | 0.85% |
| Lupin | -1.30% | -1.88% | 1.33% | 10.65% | 9.97% | 0.16% |
Executive Chairman : Samir Mehta
Independent Director : Ameera Shah
Independent Director : Nayantara Bali
Managing Director : Aman Mehta
Independent Director : Manish Choksi
Company Sec. & Compli. Officer : Chintan Trivedi
Independent Director : Nikhil Khattau
Non Executive Director : Jindal Mehta